These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 15705640)
1. Linezolid in the treatment of Gram-positive prosthetic joint infections. Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640 [TBL] [Abstract][Full Text] [Related]
2. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Rao N; Hamilton CW Diagn Microbiol Infect Dis; 2007 Oct; 59(2):173-9. PubMed ID: 17574788 [TBL] [Abstract][Full Text] [Related]
4. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid. Wareham DW; Abbas H; Karcher AM; Das SS J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052 [TBL] [Abstract][Full Text] [Related]
5. Experience with linezolid therapy in children with osteoarticular infections. Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803 [TBL] [Abstract][Full Text] [Related]
6. Linezolid treatment of shunt-related cerebrospinal fluid infections in children. Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254 [TBL] [Abstract][Full Text] [Related]
7. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections]. Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350 [TBL] [Abstract][Full Text] [Related]
8. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA). Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523 [TBL] [Abstract][Full Text] [Related]
9. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840 [TBL] [Abstract][Full Text] [Related]
10. Early experience with linezolid for infections in orthopaedics. Harwood PJ; Talbot C; Dimoutsos M; Sunderland G; Shaw D; Wilcox MH; Giannoudis PV Injury; 2006 Sep; 37(9):818-26. PubMed ID: 16620816 [TBL] [Abstract][Full Text] [Related]
12. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141 [TBL] [Abstract][Full Text] [Related]
13. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Chien JW; Kucia ML; Salata RA Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of linezolid in liver transplant patients. Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969 [TBL] [Abstract][Full Text] [Related]
15. Impact of prolonged treatment with linezolid on the human gut flora. Kofteridis DP; Malliotakis P; Maraki S; Christofaki M; Samonis G Int J Infect Dis; 2009 Sep; 13(5):e313-5. PubMed ID: 19395298 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Nguyen S; Pasquet A; Legout L; Beltrand E; Dubreuil L; Migaud H; Yazdanpanah Y; Senneville E Clin Microbiol Infect; 2009 Dec; 15(12):1163-9. PubMed ID: 19438638 [TBL] [Abstract][Full Text] [Related]
17. Linezolid for the treatment of infections caused by Gram-positive pathogens in China. Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341 [TBL] [Abstract][Full Text] [Related]
18. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid]. Krueger WA; Unertl KE Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745 [TBL] [Abstract][Full Text] [Related]
19. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142 [TBL] [Abstract][Full Text] [Related]
20. Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis. Colli A; Campodonico R; Gherli T Ann Thorac Surg; 2007 Jul; 84(1):87-91. PubMed ID: 17588391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]